715 related articles for article (PubMed ID: 31083442)
1. Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It?
Govindpani K; McNamara LG; Smith NR; Vinnakota C; Waldvogel HJ; Faull RL; Kwakowsky A
J Clin Med; 2019 May; 8(5):. PubMed ID: 31083442
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between neurovascular dysfunction and Aβ in Alzheimer's disease.
Wang N; Yang X; Zhao Z; Liu D; Wang X; Tang H; Zhong C; Chen X; Chen W; Meng Q
Front Mol Neurosci; 2023; 16():1227493. PubMed ID: 37654789
[TBL] [Abstract][Full Text] [Related]
4. Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid beta.
Lozupone M; Panza F
Neural Regen Res; 2024 Jan; 19(1):80-83. PubMed ID: 37488848
[TBL] [Abstract][Full Text] [Related]
5. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
6. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
Canepa E; Fossati S
Front Neurol; 2020; 11():573324. PubMed ID: 33488493
[TBL] [Abstract][Full Text] [Related]
7. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.
Standridge JB
Curr Alzheimer Res; 2006 Apr; 3(2):95-108. PubMed ID: 16611010
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
10. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
11. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
Janota C; Lemere CA; Brito MA
Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
[TBL] [Abstract][Full Text] [Related]
13. Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer's disease.
Ortner M; Kurz A; Alexopoulos P; Auer F; Diehl-Schmid J; Drzezga A; Förster S; Förstl H; Perneczky R; Sorg C; Yousefi BH; Grimmer T
Biol Psychiatry; 2015 Apr; 77(8):704-10. PubMed ID: 24613195
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction.
Bandyopadhyay S
Front Aging Neurosci; 2021; 13():653334. PubMed ID: 34211387
[TBL] [Abstract][Full Text] [Related]
16. Vascular and metabolic dysfunction in Alzheimer's disease: a review.
Murray IV; Proza JF; Sohrabji F; Lawler JM
Exp Biol Med (Maywood); 2011 Jul; 236(7):772-82. PubMed ID: 21680755
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
[TBL] [Abstract][Full Text] [Related]
18. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
Boese AC; Hamblin MH; Lee JP
Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
20. Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.
Grossmann K
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
